Joints in Scleroderma: Hydroxyapatite Disease

Rozin Alexander; Daood Rula; Balbir-Gurman Alexandra

doi:10.54646/bijgim.2022.04

PDF HTML EPUB XML

Abstract Views: 51

PDF Views/Downloads: 57

HTML Views/Downloads: 13

EPUB Views/Downloads: 33

XML Views/Downloads: 36

How to Cite

Alexander, R., Rula, D., & Alexandra, B.-G. (2022). Joints in Scleroderma: Hydroxyapatite Disease. BOHR International Journal of General and Internal Medicine, 1(1), 14–16. https://doi.org/10.54646/bijgim.2022.04

Published: Sep 2, 2022

DOI: https://doi.org/10.54646/bijgim.2022.04

Dimensions Citation count:

Keywords:

Scleroderma
hydroxyapatite crystals
joints

Authors

Rozin Alexander

B. Shine Rheumatology Institute, Rambam Health Care Campus, Technion, Haifa, Israel

Daood Rula

B. Shine Rheumatology Institute, Rambam Health Care Campus, Technion, Haifa, Israel

Balbir-Gurman Alexandra

B. Shine Rheumatology Institute, Rambam Health Care Campus, Technion, Haifa, Israel

Abstract

We report an inflammatory mechanism of joint damage in systemic sclerosis (SS) associated with hydroxyapatite (HA) deposits. This is an unusual asymptomatic case with an unusual localization of severe metatarsal–phalangeal joint disease. The patient had no hyperuricemia. We review the literature about HA deposit disease and discuss variable joint involvement in SS.

Share This Article On Social Media

Usage Statistics